Further analysis including a larger number of patients and studies is necessary to evaluate the prognostic role of c-Met in Asian breast cancer patients, and to determine whether c-Met status has a different influence on the prognosis of Asian and Western breast cancer patients. This evidence concerns the gene MET and breast carcinoma.